Switzerland· 56068004
Cefavora, Tropfen zum Einnehmen
A medicinal product containing ginkgo biloba (hab) tm, viscum album tm, crataegus e fructibus recentibus tm, registered in Switzerland by steinberg pharma ag and dispensed under Swissmedic category D.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
The record
At a glance
Swissmedic (Switzerland)- Active substance
- ginkgo biloba (HAB) TM, viscum album TM, crataegus e fructibus recentibus TM
- Manufacturer
- steinberg pharma ag
- Country
- Switzerland (CH)
- ATC code
- —
- Swissmedic category
- D
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfa37f94-8db4-4cd5-bf52-2ef7a2203bc5 GET /v1/drugs/cfa37f94-8db4-4cd5-bf52-2ef7a2203bc5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about ginkgo biloba (hab) tm, viscum album tm, crataegus e fructibus recentibus tm.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.